• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

VP-16-213 monotherapy for remission induction of small cell lung cancer: a randomized trial using three dosage schedules.

作者信息

Cavalli F, Sonntag R W, Jungi F, Senn H J, Brunner K W

出版信息

Cancer Treat Rep. 1978 Mar;62(3):473-5.

PMID:348319
Abstract
摘要

相似文献

1
VP-16-213 monotherapy for remission induction of small cell lung cancer: a randomized trial using three dosage schedules.
Cancer Treat Rep. 1978 Mar;62(3):473-5.
2
Phase II clinical trial of weekly administration of VP-16-213 in small cell bronchogenic carcinoma.
Cancer Treat Rep. 1977 May-Jun;61(3):489-90.
3
[A phase II study of intravenous VP-16-213 in small cell and non-small cell carcinoma of the lung].
Gan To Kagaku Ryoho. 1986 Apr;13(4 Pt 1):931-7.
4
[Treatment of anaplastic carcinoma of the lung with VP 16-213].
Med Clin (Barc). 1982;79(7):322-4.
5
[A phase II study of oral VP-16 in primary lung cancer].
Gan To Kagaku Ryoho. 1985 Sep;12(9):1801-7.
6
[A phase II study of etoposide (VP-16) injection in primary lung cancer by cooperative study group].
Gan To Kagaku Ryoho. 1986 Jan;13(1):116-21.
7
Therapeutic trials with VP-16-213 and VM-26: active agents in small cell lung cancer, non-Hodgkin's lymphomas, and other malignancies.
Cancer Treat Rep. 1979 Aug;63(8):1231-9.
8
Response rate and toxicity of etoposide (VP-16) in squamous carcinoma of the lung: report from the Lung Cancer Treatment Study Group.依托泊苷（VP - 16）治疗肺鳞状细胞癌的缓解率和毒性：肺癌治疗研究组报告
Semin Oncol. 1985 Mar;12(1 Suppl 2):21-2.
9
[Phase II study of VP-16 in patients with primary bronchogenic carcinoma, with special reference to small cell carcinoma--a multi-institutional cooperative study].
Nihon Gan Chiryo Gakkai Shi. 1986 Feb 20;21(1):12-8.
10
[Phase II study of etoposide in patients with lung cancer, with special reference to small cell carcinoma].
Nihon Gan Chiryo Gakkai Shi. 1986 Feb 20;21(1):108-11.

引用本文的文献

1
Chemotherapy advances in small-cell lung cancer.小细胞肺癌的化疗进展
J Thorac Dis. 2013 Oct;5 Suppl 5(Suppl 5):S565-78. doi: 10.3978/j.issn.2072-1439.2013.07.43.
2
Inhibition of tumor angiogenesis by oral etoposide.口服依托泊苷对肿瘤血管生成的抑制作用。
Exp Ther Med. 2010 Sep;1(5):739-746. doi: 10.3892/etm.2010.127. Epub 2010 Jul 21.
3
Pharmacokinetic optimisation of treatment with oral etoposide.口服依托泊苷治疗的药代动力学优化
Clin Pharmacokinet. 2004;43(7):441-66. doi: 10.2165/00003088-200443070-00002.
4
The health-related quality of life and survival of small-cell lung cancer patients: results of a companion study to CALGB 9033.小细胞肺癌患者的健康相关生活质量与生存情况：CALGB 9033伴随研究的结果
Qual Life Res. 2002 May;11(3):235-48. doi: 10.1023/a:1015257121369.
5
Oral etoposide in patients with hematological malignancies: a clinical and pharmacokinetic study.口服依托泊苷治疗血液系统恶性肿瘤患者：一项临床和药代动力学研究。
Med Oncol. 2001;18(4):269-75. doi: 10.1385/MO:18:4:269.
6
Treatment and outcomes for elderly patients with small cell lung cancer.老年小细胞肺癌患者的治疗与预后
Drugs Aging. 2000 Sep;17(3):229-47. doi: 10.2165/00002512-200017030-00006.
7
The role of oral etoposide in non-small cell lung cancer.口服依托泊苷在非小细胞肺癌中的作用。
Drugs. 1999;58 Suppl 3:21-30. doi: 10.2165/00003495-199958003-00004.
8
Phase II trial of carboplatin plus oral etoposide for elderly patients with small-cell lung cancer.卡铂联合口服依托泊苷治疗老年小细胞肺癌的II期试验
Br J Cancer. 1998 Jun;77(11):1961-5. doi: 10.1038/bjc.1998.325.
9
Cisplatin and etoposide in oesophageal cancer: a phase II study. Rotterdam Oesophageal Tumour Study Group.顺铂和依托泊苷用于食管癌治疗：一项II期研究。鹿特丹食管癌研究组
Br J Cancer. 1996 Sep;74(6):980-4. doi: 10.1038/bjc.1996.469.
10
Therapeutic drug monitoring in 21-day oral etoposide treatment for lung cancer.21天口服依托泊苷治疗肺癌的治疗药物监测
Jpn J Cancer Res. 1996 Aug;87(8):856-61. doi: 10.1111/j.1349-7006.1996.tb02111.x.